Efficacy and mechanism of Tongxinluo capsule in treating angina pectoris of coronary heart disease with Qi deficiency and blood stasis
DUAN Bingjun
LIN Dezhi
XIONG Fuquan
WANG Xiaobing
HUANG Le
Abstract:Objective To observe the therapeutic effect and mechanism of Tongxinluo capsule in treating angina pec-toris of coronary heart disease with Qi deficiency and blood stasis.Methods One hundred and five cases of coronary heart disease with Qi deficiency and blood stasis were randomly divided into 2 groups, 51 cases in the control group and 53 cases in the observation group.Control group was treated with routine treatment;the observation group added Tongxinluo capsule on the basis of control group(4 pills additionally, 3 times daily, 4 weeks for a course of treatment, continuous treatment 3 courses. The content of serum IL-6 and IL-18, blood lipid and clinical efficacy were observed and compared between the 2 groups be-fore and after treatment.Results After treatment, the total effective rate of observation group was higher than the control group (94.3%vs.75.5%,χ2 =6.949, P =0.003).Comparison of the efficacy of ECG in 2 groups after treatment, the total effective rate of observation group was higher than the control group (90.8% vs.70.6%,χ2 =8.777, P =0.032).In the observation group, the number of angina attacks per week was lower than that of the control group ( t =4.405, P =0.001), and the duration of angina was significantly shorter than that of the control group ( t =5.074, P =0.000).The observation group patients serum IL-6 and IL-18 levels were lower than the control group ( t =7.708, P =0.001;t =13.088, P =0.000) , TC, TG and LDL-C levels were also significantly lower than the control group ( t =10.097, P =0.003;t =4.115, P =0.023;t =4.312, P =0.029);while the HDL-C level of patients before and after treatment in the 2 groups had no sig-nificant change ( t =0.544, t =0.612, P =0.493, P =0.885).Conclusion Tongxinluo capsule in the treatment of coro-nary heart disease with Qi deficiency and blood stasis has good clinical effect, and its mechanism may be related to the regula-tion of inflammatory factor IL-6 and IL-18.
Keywords:Tongxinluo capsuleCoronary heart diseaseAngina pectorisIL-6IL-18Therapeutic effect
Publication Date:2016-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:4( 1065-1068 )
